DZ1998A1 - Dérivés de n-(3-benzofuranyl)-urée. - Google Patents

Dérivés de n-(3-benzofuranyl)-urée.

Info

Publication number
DZ1998A1
DZ1998A1 DZ960039A DZ960039A DZ1998A1 DZ 1998 A1 DZ1998 A1 DZ 1998A1 DZ 960039 A DZ960039 A DZ 960039A DZ 960039 A DZ960039 A DZ 960039A DZ 1998 A1 DZ1998 A1 DZ 1998A1
Authority
DZ
Algeria
Prior art keywords
benzofuranyl
urea derivatives
urea
derivatives
Prior art date
Application number
DZ960039A
Other languages
English (en)
Inventor
Gabriel Braulich
Rudiger Fischer
Mazen Es-Sayed
Michael Sperzel
Karl-Heinz Schlemmer
Stephen Tudhope
Graham Sturton
Trevor Abram
Mary F Fitzeral
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DZ1998A1 publication Critical patent/DZ1998A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Cosmetics (AREA)
DZ960039A 1995-03-06 1996-03-05 Dérivés de n-(3-benzofuranyl)-urée. DZ1998A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504460.8A GB9504460D0 (en) 1995-03-06 1995-03-06 N-(3-Benzofuranyl)urea-derivatives

Publications (1)

Publication Number Publication Date
DZ1998A1 true DZ1998A1 (fr) 2002-07-20

Family

ID=10770709

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ960039A DZ1998A1 (fr) 1995-03-06 1996-03-05 Dérivés de n-(3-benzofuranyl)-urée.

Country Status (42)

Country Link
US (2) US6399657B1 (fr)
EP (1) EP0731099B1 (fr)
JP (1) JP3204901B2 (fr)
KR (2) KR100405579B1 (fr)
CN (2) CN1134419A (fr)
AR (1) AR002710A1 (fr)
AT (1) ATE193704T1 (fr)
BG (2) BG100396A (fr)
BR (1) BR9600930A (fr)
CA (1) CA2170824A1 (fr)
CO (1) CO4370145A1 (fr)
CZ (1) CZ66796A3 (fr)
DE (1) DE69608721T2 (fr)
DK (1) DK0731099T3 (fr)
DZ (1) DZ1998A1 (fr)
EE (1) EE03921B1 (fr)
ES (1) ES2147320T3 (fr)
FI (1) FI960998A (fr)
GB (1) GB9504460D0 (fr)
GR (1) GR3034240T3 (fr)
HK (1) HK1013285A1 (fr)
HR (1) HRP960071B1 (fr)
HU (1) HU222282B1 (fr)
IL (1) IL117349A (fr)
MA (1) MA23815A1 (fr)
MY (1) MY117526A (fr)
NO (1) NO313672B1 (fr)
NZ (1) NZ286107A (fr)
PE (1) PE43597A1 (fr)
PL (1) PL189206B1 (fr)
PT (1) PT731099E (fr)
RO (1) RO116622B1 (fr)
RU (1) RU2162845C2 (fr)
SI (1) SI0731099T1 (fr)
SK (1) SK281817B6 (fr)
SV (1) SV1996000015A (fr)
TN (1) TNSN96035A1 (fr)
TR (1) TR199600177A2 (fr)
TW (1) TW336934B (fr)
UA (1) UA46714C2 (fr)
YU (1) YU49359B (fr)
ZA (1) ZA961774B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
JPH10168095A (ja) * 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
CA2345459A1 (fr) * 1998-11-12 2000-05-18 Regine Bohacek Inhibiteurs de transduction de signaux bicycliques, compositions les contenant et utilisation de ces dernieres
GB2350109A (en) 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
GB2350112A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active cycloalkyl ketones
GB2350110A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofurans
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
US7351735B2 (en) * 2002-02-22 2008-04-01 Bayer Pharmaceuticals Corporation Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
WO2004046095A1 (fr) 2002-11-19 2004-06-03 Achillion Pharmaceuticals, Inc. Aryl thio-urees substituees et composes analogues, inhibiteurs de la replication virale
WO2004063181A1 (fr) * 2003-01-03 2004-07-29 Genzyme Corporation Derives d'uree et leur utilisation comme agents anti-inflammatoires
TW200528459A (en) * 2004-01-06 2005-09-01 Achillion Pharmaceuticals Inc Azabenzofuran substituted thioureas; inhibitors of viral replication
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2006137350A1 (fr) * 2005-06-22 2006-12-28 Kissei Pharmaceutical Co., Ltd. Nouveau dérivé de furopyridine, composition pharmaceutique comprenant le dérivé et utilisation du dérivé ou de la composition
CN101484166B (zh) 2006-07-05 2012-09-05 奈科明有限责任公司 用于治疗炎症性肺部疾病的HMG-CoA还原酶抑制剂与磷酸二酯酶4抑制剂的组合
WO2012123353A1 (fr) 2011-03-17 2012-09-20 Algiax Pharmaceuticals Gmbh Nouvelle utilisation de benzofuranylsulfonates
WO2013156232A1 (fr) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Utilisation de benzofuranylsulfonates dans la douleur neuropathique
US10472324B2 (en) 2014-03-18 2019-11-12 Algiax Pharmaceuticals Gmbh 2-cyano-3-cyclopropyl-3-hydroxy-N-aryl-thioacrylamide derivatives
EP3165224A1 (fr) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Utilisation d'inhibiteurs de pde4 pour la prophylaxie et/ou la thérapie de la dyslipoproteinémie et des troubles apparentés
WO2017089347A1 (fr) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Procédés et compositions pharmaceutiques pour le traitement de mélanomes résistant aux inhibiteurs de braf
JP6788966B2 (ja) * 2015-12-24 2020-11-25 丸善製薬株式会社 化粧料
EP4020024A1 (fr) 2020-12-22 2022-06-29 Paul Scherrer Institut Procédé de production d'optique à rapport de forme élevé en forme de ventilateur

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU559687B2 (en) * 1981-07-01 1987-03-19 Upjohn Company, The Pyridinyl-and imidazolyl-benzofurane and benzothiophenes
EP0146243A1 (fr) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Inhibiteurs de la lipoxygénase
US4822803A (en) * 1983-10-31 1989-04-18 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis
US4933351A (en) * 1983-10-31 1990-06-12 Merck Frosst Canada, Inc. Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
US5087638A (en) * 1984-06-20 1992-02-11 Merck Frosst Canada, Inc. Benzofuran derivatives
GB9200623D0 (en) * 1992-01-13 1992-03-11 Bayer Ag Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives

Also Published As

Publication number Publication date
SI0731099T1 (en) 2000-08-31
HUP9600549A2 (en) 1997-07-28
CN1176651C (zh) 2004-11-24
JP3204901B2 (ja) 2001-09-04
GR3034240T3 (en) 2000-12-29
AU4582896A (en) 1996-09-19
SK281817B6 (sk) 2001-08-06
ATE193704T1 (de) 2000-06-15
MA23815A1 (fr) 1996-10-01
SK29796A3 (en) 1996-10-02
EE03921B1 (et) 2002-12-16
KR960034194A (ko) 1996-10-22
RO116622B1 (ro) 2001-04-30
TR199600177A2 (tr) 1996-10-21
HU222282B1 (hu) 2003-05-28
TW336934B (en) 1998-07-21
NZ286107A (en) 1998-08-26
IL117349A (en) 2002-09-12
UA46714C2 (uk) 2002-06-17
RU2162845C2 (ru) 2001-02-10
DK0731099T3 (da) 2000-09-25
DE69608721T2 (de) 2000-10-05
KR100438633B1 (ko) 2004-07-02
YU13396A (sh) 1999-06-15
FI960998A0 (fi) 1996-03-04
JPH08253466A (ja) 1996-10-01
BG100396A (bg) 1996-12-31
CN1134419A (zh) 1996-10-30
HRP960071A2 (en) 1997-12-31
HU9600549D0 (en) 1996-04-29
MY117526A (en) 2004-07-31
PT731099E (pt) 2000-11-30
US6677372B2 (en) 2004-01-13
NO960884D0 (no) 1996-03-05
YU49359B (sh) 2005-09-19
NO313672B1 (no) 2002-11-11
CZ66796A3 (en) 1996-09-11
US6399657B1 (en) 2002-06-04
EP0731099A1 (fr) 1996-09-11
PE43597A1 (es) 1997-12-26
TNSN96035A1 (fr) 2005-03-15
HUP9600549A3 (en) 1998-04-28
PL313070A1 (en) 1996-09-16
AU705667B2 (en) 1999-05-27
KR100405579B1 (ko) 2004-03-19
EP0731099B1 (fr) 2000-06-07
ES2147320T3 (es) 2000-09-01
US20030109578A1 (en) 2003-06-12
HRP960071B1 (en) 2001-04-30
NO960884L (no) 1996-09-09
HK1013285A1 (en) 1999-08-20
CO4370145A1 (es) 1996-10-07
PL189206B1 (pl) 2005-07-29
IL117349A0 (en) 1996-07-23
SV1996000015A (es) 1997-02-17
CA2170824A1 (fr) 1996-09-07
GB9504460D0 (en) 1995-04-26
BG62732B1 (bg) 2000-06-30
CN1313284A (zh) 2001-09-19
FI960998A (fi) 1996-09-07
AR002710A1 (es) 1998-04-29
BR9600930A (pt) 1997-12-30
DE69608721D1 (de) 2000-07-13
EE9600030A (et) 1996-10-15
ZA961774B (en) 1996-09-17

Similar Documents

Publication Publication Date Title
DZ1998A1 (fr) Dérivés de n-(3-benzofuranyl)-urée.
NL300214I1 (nl) Chinazolinederivaten.
PT833828E (pt) Derivados de rapamicina
OA09358A (fr) Dérivés azoliques.
DK0876392T3 (da) Lacton-derivater af 17.beta.-carboxy, carbothio og amidandrostanforbindelser
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
TR199600883A2 (tr) Pürin-6-on türevleri.
DZ1514A1 (fr) Dérivés de benzèneacetamides.
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
TR199600715A2 (tr) Kefalosforin türevleri.
PT856007E (pt) Derivados de ciclopeptidos
BR9610597A (pt) Derivados de diarilalcenilamina
FR2713641B1 (fr) Dérivés de l'épi-épibatidine.
FR2716192B1 (fr) Dérivés de 2-imidazoline-5-ones fongicides.
TR199600064A2 (tr) 4-amino-benzoilguanidin-türevleri.
DZ1985A1 (fr) Dérivés d'indole substitués.
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
PT843675E (pt) Derivados de aza-antraciclinona
TR199600067A2 (tr) 4-merkapto-benzoil guanidin türevleri.
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
DZ2597A1 (fr) Dérivés d'urée.
MA23936A1 (fr) Dimaleate de n,n-diethyl-8, 8-dipropyl-2-azaspiro (4,5) decane -2-propanamine
BR9510036A (pt) Derivados de 1,3,4-oxadiazina
FR2721022B1 (fr) Dérivés de 5-imino 2-imidazolines fongicides.
DE29500160U1 (de) Vierfachspender